Ligustrazine protects against chronic hypertensive glaucoma in rats by inhibiting autophagy via the PI3K-Akt/mTOR pathway

PURPOSE: Glaucoma is a leading cause of global irreversible blindness, and characterized by the progressive loss of retinal ganglion cells (RGCs). Ligustrazine (TMP) is a natural product that has shown beneficial effects on various diseases. This study aimed to determine whether ligustrazine produce...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Hong-yan, Wang, Rong, Li, Jian-liang, Luo, Huang, Xie, Xiao-yan, Yan, Ran, Jian, Yue-ling, Cai, Jin-ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711580/
https://www.ncbi.nlm.nih.gov/pubmed/35035207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711580/
https://www.ncbi.nlm.nih.gov/pubmed/35035207

Ejemplares similares